Taiyo, hedge fund sponsor, to acquire 5% of KH Neochem, chemical company. “We like the niche positioning of KH Neochem. Their focus on chemical production and their use of the difficult-to-imitate OXO technology creates high barriers to entry. President Takahashi has positioned the company to execute the long term growth plan and provide excellent shareholder returns. We believe further market recognition of KH Neochem will complement his efforts.” Brian K. Heywood Taiyo Chief Executive Officer and Managing Partner.